ATE98876T1 - Pharmazeutische praeparate. - Google Patents

Pharmazeutische praeparate.

Info

Publication number
ATE98876T1
ATE98876T1 AT88119741T AT88119741T ATE98876T1 AT E98876 T1 ATE98876 T1 AT E98876T1 AT 88119741 T AT88119741 T AT 88119741T AT 88119741 T AT88119741 T AT 88119741T AT E98876 T1 ATE98876 T1 AT E98876T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparations
active agent
reservoir
pharmaceutical composition
provides
Prior art date
Application number
AT88119741T
Other languages
English (en)
Inventor
Thomas Kissel
Henriette Schrank
Hans-Rainer Hoffmann
Original Assignee
Sandoz Ag
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag, Lohmann Therapie Syst Lts filed Critical Sandoz Ag
Application granted granted Critical
Publication of ATE98876T1 publication Critical patent/ATE98876T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AT88119741T 1984-03-01 1988-11-26 Pharmazeutische praeparate. ATE98876T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH100884 1984-03-01
CH175384 1984-04-06
EP88119741A EP0315218B1 (de) 1984-03-01 1985-02-22 Pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
ATE98876T1 true ATE98876T1 (de) 1994-01-15

Family

ID=25686369

Family Applications (3)

Application Number Title Priority Date Filing Date
AT85810072T ATE89750T1 (de) 1984-03-01 1985-02-22 Pharmazeutische zusammensetzungen.
AT88119741T ATE98876T1 (de) 1984-03-01 1988-11-26 Pharmazeutische praeparate.
AT88119735T ATE103819T1 (de) 1984-03-01 1988-11-26 Pharmazeutische praeparate.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT85810072T ATE89750T1 (de) 1984-03-01 1985-02-22 Pharmazeutische zusammensetzungen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT88119735T ATE103819T1 (de) 1984-03-01 1988-11-26 Pharmazeutische praeparate.

Country Status (18)

Country Link
EP (3) EP0315219B1 (de)
JP (2) JPH0667835B2 (de)
KR (1) KR920010392B1 (de)
AT (3) ATE89750T1 (de)
AU (2) AU578275B2 (de)
CA (1) CA1257837A (de)
DE (4) DE3587698T2 (de)
DK (2) DK175774B1 (de)
GR (1) GR850507B (de)
HK (2) HK157896A (de)
HU (1) HU197847B (de)
IE (2) IE81316B1 (de)
IL (1) IL74446A (de)
MY (1) MY101919A (de)
NZ (1) NZ211248A (de)
PH (1) PH24392A (de)
PT (1) PT80033B (de)
WO (1) WO1985003878A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
WO1996024377A1 (de) * 1995-02-10 1996-08-15 Christian Noe Partikuläre arzneiform
US6165988A (en) * 1995-02-10 2000-12-26 Christian Noe Medicament in particulate form
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
EP1170006B8 (de) * 1999-12-14 2008-03-19 Teikoku Seiyaku Co., Ltd. Arzneimittel zur behandlung der hemicrania
DE10011447A1 (de) * 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
KR101725832B1 (ko) * 2009-05-01 2017-04-11 히사미쓰 세이야꾸 가부시키가이샤 경피 흡수형 제제
KR101690765B1 (ko) * 2015-04-17 2016-12-28 동아제약 주식회사 항진균성 활성물질을 포함하는 경피 제제
WO2017037812A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
WO2018199018A1 (ja) * 2017-04-26 2018-11-01 ニプロ株式会社 経皮吸収型製剤およびその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
CH653256A5 (en) * 1981-04-06 1985-12-31 Sandoz Ag Microemulsion for cutaneous use
DE3271647D1 (en) * 1981-07-08 1986-07-17 Key Pharma Polymeric diffusion matrix containing propranolol
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
JPS5925320A (ja) * 1982-08-02 1984-02-09 Watanabe Yakuhin Kogyo Kk 薬物投与用貼付剤
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating

Also Published As

Publication number Publication date
IE61754B1 (en) 1994-11-30
ATE103819T1 (de) 1994-04-15
AU4065085A (en) 1985-09-24
EP0315219A3 (de) 1991-03-06
HUT41644A (en) 1987-05-28
IL74446A0 (en) 1985-05-31
DE3587048D1 (de) 1993-03-11
PT80033A (en) 1985-03-01
EP0315218A3 (de) 1991-03-06
DE3587048T2 (de) 1993-06-03
DK324687A (da) 1987-06-25
CA1257837A (en) 1989-07-25
PH24392A (en) 1990-06-13
KR850700218A (ko) 1985-12-26
JPH0748253A (ja) 1995-02-21
JPH0667835B2 (ja) 1994-08-31
AU1662688A (en) 1988-10-20
HK220096A (en) 1997-01-03
JPS61501324A (ja) 1986-07-03
DK324687D0 (da) 1987-06-25
HK157896A (en) 1996-08-30
IL74446A (en) 1990-11-29
DE3587358D1 (de) 1993-07-01
DE3587698D1 (de) 1994-02-03
WO1985003878A1 (en) 1985-09-12
DE3587794T2 (de) 1994-08-04
EP0315218B1 (de) 1993-12-22
EP0315218A2 (de) 1989-05-10
GR850507B (de) 1985-06-28
EP0315219A2 (de) 1989-05-10
EP0155229A2 (de) 1985-09-18
IE940083L (en) 1985-09-01
DE3587358T2 (de) 1993-11-04
EP0155229B1 (de) 1993-05-26
DK164257B (da) 1992-06-01
DK502985D0 (da) 1985-10-31
EP0315219B1 (de) 1993-01-27
KR920010392B1 (ko) 1992-11-27
IE81316B1 (en) 2000-09-20
NZ211248A (en) 1988-10-28
AU578275B2 (en) 1988-10-20
AU607496B2 (en) 1991-03-07
DE3587698T2 (de) 1994-04-28
DK502985A (da) 1985-10-31
DK175774B1 (da) 2005-02-14
IE850493L (en) 1985-09-01
HU197847B (en) 1989-06-28
ATE89750T1 (de) 1993-06-15
JP2540019B2 (ja) 1996-10-02
MY101919A (en) 1992-02-15
DK164257C (da) 1992-10-19
EP0155229A3 (en) 1985-12-11
PT80033B (pt) 1987-10-20
DE3587794D1 (de) 1994-05-11

Similar Documents

Publication Publication Date Title
DE3587794T2 (de) Pharmazeutische Präparate.
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
PT93191A (pt) Sistema terapeutico para a administracao retardada e controlada transdermica ou transmucosica de substancias activas
DK676987A (da) Nasaloploesninger
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
ES2043719T3 (es) Administracion de farmacos por via percutanea.
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
EP0380989A3 (en) Plaster for transdermal administration
ATE84975T1 (de) Pharmazeutische praeparate.
IL89251A (en) Pharmaceutical compositions for the systemic transdermal administration of pharmacologically active agents

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time